Amy E Rothberg
Amy E Rothberg is an expert in Endocrinology at University of Michigan–Ann Arbor (United States). As of October 2026, ScienceLeadR ranks Amy E Rothberg in the top 1% of experts worldwide for Body Weight. Amy E Rothberg has authored 77 publications, the most recent in 2026, and is an investigator in 6 clinical trials. SLR score: 283 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Pharmacy - Internal Medicine - Nephrology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2002 - 2026
Number : 77
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| A survey of primary care physicians' views on supporting patients who lose insurance coverage for Glucagon-Like Peptide-1-based drugs for weight management. PMID 42494804 — glucagon-like peptide 1, pharmaceutical preparations, insurance coverage, academic medical centers, insurance, physicians, weight loss, glucagon, therapeutics, physicians, primary care, glucagon-like peptides, weight control | Obes Pillars | 2026 | 0 |
| Utilization and outcomes of nutrient-stimulated hormone therapies in patients undergoing bariatric surgery. PMID 42477476 — diabetes mellitus, nutrients, prescriptions, hormones, food, bariatric surgery, obesity, weight loss, therapeutics | Int J Obes (Lond) | 2026 | 0 |
| Defining disease or delaying care? A conceptual and clinical appraisal of the Lancet obesity framework. PMID 41925581 — endocrinology, research design, adiposity, work, obesity | J Clin Endocrinol Metab | 2026 | 0 |
| Challenging the Consensus Statement: Is It Time to Recognise Pharmacological Remission of Type 2 Diabetes? PMID 41852334 — diabetes mellitus, life style, bariatric surgery, therapeutics, diabetes mellitus, type 2, weight control | Diabetes Obes Metab | 2026 | 0 |
| Lifestyle Change Interventions: Effectiveness of REWIND, a Virtual, Community-Based Weight Management Program. PMID 41079537 — diabetes mellitus, life style, obesity, weight loss, weight control | Obes Sci Pract | 2025 | 0 |
Clinical Studies 6
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map